MY142256A - Compositions and methods for topical diagnostic and therapeutic transport - Google Patents
Compositions and methods for topical diagnostic and therapeutic transportInfo
- Publication number
- MY142256A MY142256A MYPI20064148A MY142256A MY 142256 A MY142256 A MY 142256A MY PI20064148 A MYPI20064148 A MY PI20064148A MY 142256 A MY142256 A MY 142256A
- Authority
- MY
- Malaysia
- Prior art keywords
- compositions
- methods
- delivery
- topical
- diagnostic
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
COMPOSITIONS AND METHODS ARE PROVIDED THAT ARE USEFUL FOR THE DELIVERY, INCLUDING TRANSDERMAL DELIVERY, OF BIOLOGICALLY ACTIVE AGENTS, SUCH AS NON-PROTEIN NON-NUCLEOTIDE THERAPEUTICS AND PROTEIN-BASED THERAPEUTICS EXCLUDING INSULIN, BOTULINUM TOXINS, ANTIBODY FRAGMENTS, AND VEGF. THE COMPOSITIONS AND METHODS ARE PARTICULARLY USEFUL FOR TOPICAL DELIVERY OF ANTIFUNGAL AGENTS AND ANTIGENIC AGENTS SUITABLE FOR IMMUNIZATION. ALTERNATELY, THE COMPOSITIONS CAN BE PREPARED WITH COMPONENTS USEFUL FOR TARGETING THE DELIVERY OF THE COMPOSITIONS AS WELL AS IMAGING COMPONENTS.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20064148 MY142256A (en) | 2006-09-14 | 2006-09-14 | Compositions and methods for topical diagnostic and therapeutic transport |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20064148 MY142256A (en) | 2006-09-14 | 2006-09-14 | Compositions and methods for topical diagnostic and therapeutic transport |
Publications (1)
Publication Number | Publication Date |
---|---|
MY142256A true MY142256A (en) | 2010-11-15 |
Family
ID=47320801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20064148 MY142256A (en) | 2006-09-14 | 2006-09-14 | Compositions and methods for topical diagnostic and therapeutic transport |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY142256A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11332518B2 (en) | 2008-03-14 | 2022-05-17 | Allergan, Inc. | Immuno-based botulinum toxin serotype A activity assays |
-
2006
- 2006-09-14 MY MYPI20064148 patent/MY142256A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11332518B2 (en) | 2008-03-14 | 2022-05-17 | Allergan, Inc. | Immuno-based botulinum toxin serotype A activity assays |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG150570A1 (en) | Compositions and methods for topical diagnostic and therapeutic transport | |
SG150569A1 (en) | Multi-component biological transport systems | |
MX344727B (en) | IMPROVED HIGH CONCENTRATION ANTI-TNFa ANTIBODY LIQUID FORMULATIONS. | |
MX2009012343A (en) | Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto. | |
CY1118153T1 (en) | TREATMENT OF MICROBIAL INFECTIONS | |
WO2009126292A3 (en) | Biologically active peptidomimetic macrocycles | |
NZ711373A (en) | Fragments of p97 and uses thereof | |
TN2014000148A1 (en) | Antigen binding protein and its use as addressing product for the treatment of cancer | |
MX2016002152A (en) | Method for increasing expression of rna-encoded proteins. | |
MX359449B (en) | Anti-cd70 antibody drug conjugates. | |
AU2018256498A1 (en) | Antibodies to amyloid beta | |
MX2012010114A (en) | Concentrated protein formulations and uses thereof. | |
WO2009109927A3 (en) | Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer | |
MX357193B (en) | Anti-alpha synuclein binding molecules. | |
MX358013B (en) | Material and methods for treating or preventing her-3 associated diseases. | |
TN2011000229A1 (en) | Antibody formulation | |
ECSP088962A (en) | NEW HERBICIDES | |
WO2012064792A3 (en) | Protein complexes for antigen binding and methods of use | |
MX2013007067A (en) | Anti-il-18 antibodies and their uses. | |
MX2009007691A (en) | Pegylated aî² fab. | |
MX2013015324A (en) | Wap domain fusion polypeptides and methods of use thereof. | |
MA32288B1 (en) | New antibodies useful for cancer treatment | |
WO2008085987A3 (en) | Drug delivery to human tissues by single chain variable region antibody fragments cloned by phage display | |
WO2014204988A3 (en) | 5t4-targeted immunofusion molecule and methods | |
EA201491369A1 (en) | METHOD OF TREATING DIABETES MELLITUS WITH NON-GLYCOLYNED APOLYPOPROTEIN A-IV |